Seelos Therapeutics, Inc. Accretion Expense
Seelos Therapeutics, Inc. reported Accretion Expense of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2016-03-09
- Seelos Therapeutics, Inc. accretion expense for the quarter ending 2014-12-31 was $0.00.
- Seelos Therapeutics, Inc. accretion expense for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- Seelos Therapeutics, Inc. accretion expense for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- Seelos Therapeutics, Inc. accretion expense for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- Seelos Therapeutics, Inc. accretion expense for fiscal 2015 was $0.00.
- Seelos Therapeutics, Inc. accretion expense for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- Seelos Therapeutics, Inc. accretion expense for fiscal 2013 was $242.00K.
- Seelos Therapeutics, Inc. accretion expense for fiscal 2012 was $0.00.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-09 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $0.00 derived: sum of 2 quarters · filed 2016-03-09 | $0.00 derived: sum of 3 quarters · filed 2016-03-09 | $0.00 10-K · filed 2016-03-09 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2016-03-09 | $68.00K derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-03-09 | $68.00K derived: sum of 3 quarters · filed 2016-03-09 | $152.00K derived: sum of 4 quarters · filed 2016-03-09 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $68.00K derived: sum of 2 quarters · filed 2016-03-09 | $152.00K derived: sum of 3 quarters · filed 2016-03-09 | $242.00K 10-K · filed 2016-03-09 |
| 2013-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $152.00K derived: sum of 2 quarters · filed 2014-11-10 | $242.00K 10-Q · filed 2014-11-10 | $242.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $174.00K 10-Q · filed 2014-08-11 | $174.00K derived: sum of 3 quarters · filed 2015-03-16 | -$19.72K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $90.00K 10-Q · filed 2014-05-12 | $90.00K derived: sum of 2 quarters · filed 2015-03-16 | -$103.72K derived: sum of 3 quarters · filed 2015-03-16 | -$9.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$193.72K derived: sum of 2 quarters · filed 2015-03-16 | -$99.00K derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 |
| 2012-09-30 | -$193.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$99.00K derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $94.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $193.72K 10-Q · filed 2012-08-09 | ||
| 2012-03-31 | $99.00K 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 | |||
| 2011-06-30 | $18.57K 10-Q · filed 2012-08-09 |